Funding
← Back to your selection

Goldman Sachs Alternatives

Activity from announced rounds

Activity in this selectionSeries B
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$552M
2 disclosed · full round size, not this investor’s share

By stage

Series B2

By primary sector

AI1
Biotech1

By country

Switzerland1
United States1

Rounds

2 in this selection
Higgsfield

AI video and image creation platform for professional creators and brands

$400MSeries B
Participant
Vaderis Therapeutics

Develops an oral AKT inhibitor for hereditary hemorrhagic telangiectasia

$152MSeries B
Role not disclosed